We are live on
!
Find out more
JCM
Jayhawk Capital Management Portfolio holdings
AUM
$59.9M
1-Year Est. Return
22.48%
This Fund
S&P 500
This Quarter
Est. Return
-10.52%
1 Year Est. Return
-22.48%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$155M
AUM Growth
–
Cap. Flow
+$202M
Cap. Flow
% of AUM
130.98%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
4
New
4
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CO
Global Cord Blood Corporation
CO
|
+$169M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CO
1
DELISTED
Global Cord Blood Corporation
CO
| $153M | 99.31% |
+15,437,800
| New | +$169M |
|
2
PUT
Alibaba
BABA
$279B
| $563K | 0.36% |
+155,000
| New | +$27.8M |
|
|
CO
3
CALL
DELISTED
Global Cord Blood Corporation
CO
| $444K | 0.29% |
+528,500
| New | +$5.78M |
|
Similar funds
BC
CPP
GIA
RHIC
CC
LCAM
EECFVCI
CA
Jayhawk Capital Management's Q4 2017 Portfolio in Review
Q4 2017 is the first quarter with a 13F filing on record for Jayhawk Capital Management, which disclosed 4 positions worth $155M. Its ten largest holdings account for 100% of the portfolio.
Its largest position is Global Cord Blood Corporation: 15,437,800 shares worth $153M.
- Jayhawk Capital Management's largest Q4 2017 buy was Global Cord Blood Corporation: 15,437,800 shares worth $153M.
- Jayhawk Capital Management's ten largest holdings make up 100% of its $155M portfolio in Q4 2017.
- Jayhawk Capital Management disclosed 4 positions in Q4 2017, its first 13F filing on record.
Based on Jayhawk Capital Management's 13F filing for Q4 2017, filed 14 Feb 2018.